Stockscreener 앱 받기
67.81
1.00%
0.67
Alcon Inc 주식(ALC)의 최신 뉴스
Alcon, RxSight announce collaboration to develop adjustable presbyopia-correcting IOLs - Ophthalmology Times Europe
Systane Ultra eye drops by Alcon Inc.dry-eye relief backed by a broad product family - ad-hoc-news.de
Alcon stock holds steady as the contact lens business anchors results - ad-hoc-news.de
Alcon collaborates with RxSight to develop adjustable PCIOLs - MSN
RxSight Q2 sales sink 20% as Alcon deal bolsters 2026 outlook - MSN
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook - TradingView
Alcon stock reflects steady growth as eye care demand expands - ad-hoc-news.de
Alcon stock reflects steady growth prospects as eye care demand expands globally - ad-hoc-news.de
Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know - Yahoo Finance
Alcon Inc focuses on eye care leadership as investors watch global demand - ad-hoc-news.de
Alcon focus on eye care growth and global market presence - AD HOC NEWS
Is Alcon (SWX:ALC) Cheap Following Its RxSight Collaboration And Premium P E? - simplywall.st
Is Alcon (SWX:ALC) Undervalued After Its RxSight Collaboration? - Yahoo Finance
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones? - Insider Monkey
Alcon Inc focuses on eye care growth and global expansion - ad-hoc-news.de
Systane Complete by Alcondry eye relief with lipid layer support - AD HOC NEWS
Alcon focuses on eye-care growth as global demand for vision treatments expands - Ad-hoc-news.de
RxSight: Alcon Deal Reshapes The Long-Term Growth Story (NASDAQ:RXST) - Seeking Alpha
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs - InvisionMag.com
Alcon and RxSight partner to to develop light-adjustable PCIOLs - Eyes On Eyecare
Alcon focuses on global eye care growth as a diversified medical device leader - AD HOC NEWS
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada - AOL.com
RXST: Collaboration with Alcon and product innovation offset Q2 headwinds, supporting revised 2026 outlook - TradingView
Alcon, RxSight Begin Co-Developing Presbyopia-Correcting IOLs - Medical Product Outsourcing
DAILIES TOTAL1 from Alcon Inc.daily lenses engineered for all?day comfort - ad-hoc-news.de
Stifel reiterates Hold on RxSight stock, $8 target on Alcon deal - Investing.com
Stifel reiterates Hold on RxSight stock, $8 target on Alcon deal By Investing.com - Investing.com India
Alcon focuses on eye care growth as a global leader - AD HOC NEWS
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight - Yahoo Finance
Alcon focuses on eye care growth as demand for vision treatments rises - AD HOC NEWS
Alcon focuses on eye care growth as investors watch long-term trends - AD HOC NEWS
Alcon, RxSight Partner to Develop Adjustable Presbyopia-Correcting IOLs - VisionMonday.com
Alcon Silver Announces Shareholder Approval of Arrangement - Yahoo Finance
Alcon, RxSight partner on adjustable lens technology - Investing.com UK
Alcon, RxSight partner on adjustable lens technology By Investing.com - Investing.com South Africa
Alcon (ALC) Partners with RxSight for Innovative Lens Developmen - GuruFocus
ALCON AGRXSIGHT TO RECEIVE $60 MLN UPFRONT PAYMENT UNDER AGREEMENT - Moomoo
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement - The Manila Times
Alcon and RxSight team up to develop light-adjustable cataract lenses - StreetInsider
Alcon–RxSight (NASDAQ: RXST) deal adds $60M upfront plus milestones, royalties - Stock Titan
Alcon and RxSight team up on adjustable lenses after cataract surgery - Stock Titan
Alcon focuses on eye care growth as investors watch long-term strategy - AD HOC NEWS
Price to sales forward of Alcon AG – SIX:ALC - TradingView
Alcon stock tracks its core eye care business. Investors await fresh cues. - Ad-hoc-news.de
Alcon Inc. (ALC) Stock Analysis: Eyeing A 26% Upside With Solid Buy Ratings - DirectorsTalk Interviews
Alcon focuses on ophthalmic growth as investor interest builds - AD HOC NEWS
Alcon stock holds its footing. Focus turns to the eye-care model. - AD HOC NEWS
Harding Loevner International Equity Portfolio's Alcon Inc(ALC) Holding History - GuruFocus
Alcon Inc (ALC) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100 - GuruFocus
SYSTANE Ultra from Alcon Inc.Dry eye relief built for digital days - AD HOC NEWS
Alcon Inc focuses on eye-care growth as global demand for vision treatment expands - AD HOC NEWS
List of 19 Acquisitions by Alcon (Jul 2026) - Tracxn
DAILIES TOTAL1 contact lenses from Alcon Inc.daily disposables built for long screen days - AD HOC NEWS
Enterprise value to revenue forward of Alcon AG – VIE:ALC - TradingView
Total30 contact lenses from Alcon Inc.monthly comfort with water gradient tech - AD HOC NEWS
ALCAlcon Inc Latest SEC Filings - Finviz
Alcon consensus holds steady, shares in focus on SIX Swiss Exchange - AD HOC NEWS
Systane class action claims eye drops falsely advertised as preservative-free - Class Action Lawsuits
MiniMed adds Alcon CEO and Medtronic executive to board By Investing.com - Investing.com Canada
Press Release: MiniMed Appoints Alcon CEO David Endicott and Linnea Burman to Its Board of Directors - Moomoo
Alcon opens the week with a full earnings calendar, shares steady ahead of next update - AD HOC NEWS
Top Intraocular Lens Market Companies Driving Innovation - SNS Insider
Alcon Inc. (ALC) Stock Analysis: A Healthcare Giant With A 29.68% Upside Potential - DirectorsTalk Interviews
Alcon highlights surgical portfolio ahead of Q2, shares trade steadily on SIX - AD HOC NEWS
0.47%
2.20%
자본화:
|
볼륨(24시간):